Damage to white matter in the brain can trigger features associated with neurodegenerative disease, Cambridge researchers have discovered in a new study published in the journal Nature.
Cambridge scientists have shown that when tumours first emerge, interactions with healthy cells in the underlying supportive tissue determine their ability to survive, grow, and progress to advanced stages of disease.
Meet the winners of the Cambridge Awards 2025 for Research Impact and Engagement and learn more about their projects.
The collaboration will use state-of-the-art genomics approaches in combination with machine learning methods to advance our scientific understanding of cells and tissues in health and disease.
Centre for Children's Gut Health aims to transform the physical and mental health of children and young people.
A combination of two drugs could improve outcomes and reduce the need for toxic chemotherapy for B-cell acute lymphoblastic leukaemia (B-ALL), the commonest cancer in childhood and one that can be particularly difficult to treat in older patients, according to Cambridge scientists.
Metformin, a widely used and affordable diabetes drug, could prevent a form of acute myeloid leukaemia in people at high risk of the disease, a study in mice has suggested. Further research in clinical trials will be needed to confirm this works for patients.
Two University of Cambridge researchers are among the thirty-two early career researchers, tackling issues from improving food security to developing better medical implants, who have been announced as the 2025 Schmidt Science Fellows.
Meet the winner of the Cambridge Awards 2024 for Research Impact and Engagement and learn more about their projects.
Cambridge researchers are developing implants that could help repair the brain pathways damaged by Parkinson’s disease.
© 2026 University of Cambridge